Education
About Us
Working with TipRanks
Follow Us
Palatin Technologies (PTNT)
OTHER OTC:PTNT
PTNT Stock Chart & Stats
$11.04
--
Market closed
$11.04
--
Day’s Range― - ―
52-Week Range$1.77 - $72.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.99K
Market Cap
$5.72M
Enterprise Value$4.11M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Feb 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.26
Shares Outstanding973,291
10 Day Avg. Volume2,746
30 Day Avg. Volume2,993
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.72
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Palatin Technologies News
PTNT FAQ
What was Palatin Technologies’s price range in the past 12 months?
Palatin Technologies lowest stock price was $1.77 and its highest was $72.50 in the past 12 months.
What is Palatin Technologies’s market cap?
Palatin Technologies’s market cap is $5.72M.
When is Palatin Technologies’s upcoming earnings report date?
Palatin Technologies’s upcoming earnings report date is Feb 17, 2026 which is in 65 days.
How were Palatin Technologies’s earnings last quarter?
Palatin Technologies released its earnings results on Nov 13, 2025. The company reported $4.26 earnings per share for the quarter, beating the consensus estimate of N/A by $4.26.
Is Palatin Technologies overvalued?
According to Wall Street analysts Palatin Technologies’s price is currently Overvalued.
Does Palatin Technologies pay dividends?
Palatin Technologies does not currently pay dividends.
What is Palatin Technologies’s EPS estimate?
Palatin Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Palatin Technologies have?
Palatin Technologies has 973,291 shares outstanding.
What happened to Palatin Technologies’s price movement after its last earnings report?
Palatin Technologies reported an EPS of $4.26 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.174%.
Which hedge fund is a major shareholder of Palatin Technologies?
Currently, no hedge funds are holding shares in PTNT
Company Description
Palatin Technologies
Palatin Technologies, Inc. is a biopharmaceutical company focused on developing targeted receptor-specific therapeutics for the treatment of various medical conditions. The company primarily operates in the biotechnology sector, with a strong emphasis on developing treatments for inflammatory diseases and disorders related to sexual dysfunction. Palatin's core product includes Vyleesi, a melanocortin receptor agonist indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
PTNT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, such as the successful collaboration with Boehringer Ingelheim, a return to NYSE American listing, and strong financial performance with increased revenue and net income. However, concerns about the reduced cash position and dependency on future milestones were noted. Overall, the positive aspects of strategic partnerships and financial recovery outweigh the concerns.View all PTNT earnings summariesTechnical Analysis
Ibio
―
Phio Pharmaceuticals
―
BioRestorative Therapies
―
Addex Therapeutics
―
Bolt Biotherapeutics
―